Macrophage activation syndrome in the course of monogenic autoinflammatory disorders.

Abstract

An overwhelming activation of cytotoxic T cells and well-differentiated macrophages leading to systemic overload of inflammatory mediators characterizes the so-called macrophage activation syndrome (MAS); this potentially life-threatening clinical entity may derive from several genetic defects involved in granule-mediated cytotoxicity but has been largely observed in patients with juvenile idiopathic arthritis, many rheumatologic diseases, infections, and malignancies. The occurrence of MAS in the natural history or as the revealing clue of monogenic autoinflammatory disorders (AIDs), rare conditions caused by disrupted innate immunity pathways with overblown release of proinflammatory cytokines, has been only reported in few isolated patients with cryopyrin-associated periodic syndrome, mevalonate kinase deficiency, familial Mediterranean fever, and tumor necrosis factor receptor-associated periodic syndrome since 2001. All these patients displayed various clinical, laboratory, and histopathologic features of MAS and have often required intensive care support. Only one patient has died due to MAS. Defective cytotoxic cell function was documented in a minority of patients. Corticosteroids were the first-line treatment, but anakinra was clinically effective in three refractory cases. Even if MAS and AIDs share multiple clinical features as well as heterogeneous pathogenetic scenes and a potential response to anti-interleukin-1 targeted therapies, MAS requires a prompt specific recognition in the course of AIDs due to its profound severity and high mortality rate.

• Authors: Donato Rigante, Giacomo Emmi, Michele Fastiggi, Elena Silvestri, Luca Cantarini
• Journal: Clinical rheumatology (Clin Rheumatol) Vol. 34 Issue 8 Pg. 1333-9 (Aug 2015) ISSN: 1434-9949 [Electronic] Germany
• PMID: 25846831 (Publication Type: Journal Article, Review)

Topics

• Arthritis, Juvenile (complications, immunology)
• Hereditary Autoinflammatory Diseases (complications, immunology)
• Humans
• Macrophage Activation Syndrome (complications, immunology)